195 related articles for article (PubMed ID: 30036883)
1. Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis.
Zhou LY; Zeng H; Wang S; Chen JX
Cell Physiol Biochem; 2018; 48(3):1003-1011. PubMed ID: 30036883
[TBL] [Abstract][Full Text] [Related]
2. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
[TBL] [Abstract][Full Text] [Related]
3. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
4. Conditional knockout of prolyl hydroxylase domain protein 2 attenuates high fat-diet-induced cardiac dysfunction in mice.
Zeng H; Chen JX
PLoS One; 2014; 9(12):e115974. PubMed ID: 25546437
[TBL] [Abstract][Full Text] [Related]
5. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
[TBL] [Abstract][Full Text] [Related]
6. Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice.
Wang S; Zeng H; Chen ST; Zhou L; Xie XJ; He X; Tao YK; Tuo QH; Deng C; Liao DF; Chen JX
J Cell Mol Med; 2017 Sep; 21(9):1967-1978. PubMed ID: 28266128
[TBL] [Abstract][Full Text] [Related]
7. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
[TBL] [Abstract][Full Text] [Related]
8. Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.
Li L; Saliba P; Reischl S; Marti HH; Kunze R
Neurobiol Dis; 2016 Jul; 91():221-35. PubMed ID: 27001147
[TBL] [Abstract][Full Text] [Related]
9. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.
Xie C; Yagai T; Luo Y; Liang X; Chen T; Wang Q; Sun D; Zhao J; Ramakrishnan SK; Sun L; Jiang C; Xue X; Tian Y; Krausz KW; Patterson AD; Shah YM; Wu Y; Jiang C; Gonzalez FJ
Nat Med; 2017 Nov; 23(11):1298-1308. PubMed ID: 29035368
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.
Taniguchi CM; Finger EC; Krieg AJ; Wu C; Diep AN; LaGory EL; Wei K; McGinnis LM; Yuan J; Kuo CJ; Giaccia AJ
Nat Med; 2013 Oct; 19(10):1325-30. PubMed ID: 24037093
[TBL] [Abstract][Full Text] [Related]
11. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
12. Loss of Endothelial Hypoxia Inducible Factor-Prolyl Hydroxylase 2 Induces Cardiac Hypertrophy and Fibrosis.
Dai Z; Cheng J; Liu B; Yi D; Feng A; Wang T; An L; Gao C; Wang Y; Zhu MM; Zhang X; Zhao YY
J Am Heart Assoc; 2021 Nov; 10(22):e022077. PubMed ID: 34743552
[TBL] [Abstract][Full Text] [Related]
13. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Endothelial PHD2 Suppresses Post-Ischemic Kidney Inflammation through Hypoxia-Inducible Factor-1.
Rajendran G; Schonfeld MP; Tiwari R; Huang S; Torosyan R; Fields T; Park J; Susztak K; Kapitsinou PP
J Am Soc Nephrol; 2020 Mar; 31(3):501-516. PubMed ID: 31996410
[TBL] [Abstract][Full Text] [Related]
16. Myeloid PHD2 deficiency accelerates neointima formation via Hif-1α.
Christoph M; Pfluecke C; Mensch M; Augstein A; Jellinghaus S; Ende G; Mierke J; Franke K; Wielockx B; Ibrahim K; Poitz DM
Mol Immunol; 2022 Sep; 149():48-58. PubMed ID: 35724581
[TBL] [Abstract][Full Text] [Related]
17. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
18. The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.
Kapitsinou PP; Rajendran G; Astleford L; Michael M; Schonfeld MP; Fields T; Shay S; French JL; West J; Haase VH
Mol Cell Biol; 2016 May; 36(10):1584-94. PubMed ID: 26976644
[TBL] [Abstract][Full Text] [Related]
19. The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver disease in mice.
Soofi A; Wolf KI; Ranghini EJ; Amin MA; Dressler GR
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G587-G598. PubMed ID: 27514479
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
